StockData
Chemomab Therapeutics Ltd. logo

Chemomab Therapeutics Ltd. (CMMB) stock

CMMBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 23, 2026Score 5/30
$1.53+0.13 (+9.29%)

Close on Nov 13, 2026Market cap $11.00MP/E 1.1Yield –

Chemomab Therapeutics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

No total debt figures for Chemomab Therapeutics

Chemomab Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Chemomab Therapeutics figures

See a number that looks wrong?